Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 5Unknown 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Spondylitis, Ankylosing 1Colitis, Ulcerative 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × golimumab × Clear all
NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown
300 enrolled

Spondylitis, Ankylosing

NCT02186886 2014-07-10

Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab

Kliniken im Naturpark Altmuehltal

Phase 4 Unknown
50 enrolled

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡